Best TWAS P=6.53e-15 · Best GWAS P=4.35e-14 conditioned to 0.0468
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ACTR1A | 0.03 | 0.01 | blup | 347 | 0.01 | 5.6e-02 | 4.111 | 6.5 | 1.1e-10 | 0.74 | 0.06 | 0.68 | FALSE |
2 | GTEx | Adipose Subcutaneous | CYP17A1-AS1 | 0.05 | 0.02 | enet | 10 | 0.03 | 2.8e-03 | 5.098 | 7.6 | 2.4e-14 | 0.63 | 0.10 | 0.72 | FALSE |
3 | GTEx | Adrenal Gland | TMEM180 | 0.19 | 0.15 | enet | 12 | 0.09 | 3.5e-04 | -4.120 | -6.1 | 1.3e-09 | -0.34 | 0.56 | 0.20 | FALSE |
4 | GTEx | Artery Aorta | NT5C2 | 0.08 | 0.02 | lasso | 7 | 0.01 | 1.2e-01 | -4.082 | -5.8 | 5.3e-09 | -0.55 | 0.09 | 0.74 | FALSE |
5 | GTEx | Artery Coronary | CYP17A1-AS1 | 0.20 | -0.01 | enet | 21 | 0.04 | 2.3e-02 | 0.078 | 5.2 | 2.5e-07 | 0.39 | 0.06 | 0.20 | FALSE |
6 | GTEx | Artery Tibial | NT5C2 | 0.06 | 0.04 | lasso | 9 | 0.02 | 1.5e-02 | 7.265 | -7.5 | 4.3e-14 | -0.95 | 0.04 | 0.90 | FALSE |
7 | GTEx | Artery Tibial | CYP17A1-AS1 | 0.08 | 0.08 | lasso | 8 | 0.06 | 2.8e-05 | 7.265 | 7.2 | 4.3e-13 | 0.95 | 0.03 | 0.96 | FALSE |
8 | GTEx | Brain Cerebellar Hemisphere | ARL3 | 0.15 | 0.02 | enet | 18 | 0.11 | 1.1e-03 | -5.795 | 5.8 | 9.2e-09 | 0.44 | 0.11 | 0.18 | FALSE |
9 | GTEx | Brain Cerebellum | ARL3 | 0.20 | 0.09 | enet | 32 | 0.07 | 3.7e-03 | 6.682 | 6.7 | 2.2e-11 | 0.57 | 0.09 | 0.80 | FALSE |
10 | GTEx | Brain Cerebellum | TRIM8 | 0.34 | -0.01 | enet | 25 | 0.07 | 4.7e-03 | -1.018 | -6.3 | 3.4e-10 | -0.46 | 0.07 | 0.38 | FALSE |
11 | GTEx | Brain Cortex | CYP17A1-AS1 | 0.15 | 0.13 | lasso | 7 | 0.14 | 1.3e-04 | 6.682 | 7.8 | 6.5e-15 | 0.82 | 0.07 | 0.79 | TRUE |
12 | GTEx | Brain Hypothalamus | CYP17A1-AS1 | 0.34 | 0.10 | lasso | 10 | 0.05 | 2.6e-02 | 7.352 | 7.6 | 2.2e-14 | 0.70 | 0.05 | 0.66 | FALSE |
13 | GTEx | Brain Nucleus accumbens basal ganglia | CYP17A1-AS1 | 0.39 | 0.22 | lasso | 3 | 0.19 | 8.2e-06 | 6.604 | 6.5 | 8.8e-11 | 0.84 | 0.14 | 0.43 | FALSE |
14 | GTEx | Breast Mammary Tissue | CYP17A1-AS1 | 0.10 | -0.01 | enet | 28 | 0.00 | 2.4e-01 | 7.321 | 7.2 | 8.2e-13 | 0.64 | 0.10 | 0.46 | FALSE |
15 | GTEx | Breast Mammary Tissue (Male) | CYP17A1-AS1 | 0.06 | 0.00 | lasso | 3 | 0.01 | 2.1e-01 | -6.121 | 6.8 | 9.7e-12 | 0.51 | 0.04 | 0.08 | FALSE |
16 | GTEx | Breast Mammary Tissue (Female) | TMEM180 | 0.18 | 0.06 | lasso | 4 | 0.07 | 4.5e-03 | -4.583 | -5.3 | 8.6e-08 | -0.26 | 0.25 | 0.20 | FALSE |
17 | GTEx | Breast Mammary Tissue (Female) | CYP17A1-AS1 | 0.14 | 0.01 | lasso | 11 | 0.00 | 4.7e-01 | 5.829 | 7.7 | 1.3e-14 | 0.60 | 0.06 | 0.26 | FALSE |
18 | GTEx | Cells EBV-transformed lymphocytes | ACTR1A | 0.22 | 0.18 | lasso | 3 | 0.19 | 8.0e-07 | -5.333 | 6.8 | 1.3e-11 | 0.62 | 0.46 | 0.20 | FALSE |
19 | GTEx | Cells EBV-transformed lymphocytes | RP11-18I14.11 | 0.17 | 0.08 | lasso | 8 | 0.09 | 8.7e-04 | -6.473 | 7.0 | 3.4e-12 | 0.42 | 0.21 | 0.13 | FALSE |
20 | GTEx | Cells Transformed fibroblasts | TMEM180 | 0.05 | 0.04 | lasso | 2 | 0.01 | 3.3e-02 | -6.568 | 6.6 | 4.9e-11 | 0.41 | 0.26 | 0.21 | FALSE |
21 | GTEx | Esophagus Gastroesophageal Junction | CYP17A1-AS1 | 0.23 | 0.08 | enet | 23 | 0.13 | 1.9e-05 | 6.925 | 5.7 | 1.1e-08 | 0.62 | 0.08 | 0.67 | FALSE |
22 | GTEx | Esophagus Mucosa | SUFU | 0.08 | 0.02 | enet | 18 | 0.01 | 4.2e-02 | -1.671 | -5.4 | 6.4e-08 | -0.55 | 0.62 | 0.18 | FALSE |
23 | GTEx | Esophagus Muscularis | SUFU | 0.07 | 0.04 | enet | 18 | 0.03 | 5.2e-03 | -4.348 | -6.5 | 5.9e-11 | -0.53 | 0.18 | 0.69 | FALSE |
24 | GTEx | Liver | ACTR1A | 0.15 | 0.00 | lasso | 10 | 0.00 | 4.6e-01 | -2.681 | -6.6 | 3.0e-11 | -0.52 | 0.05 | 0.34 | FALSE |
25 | GTEx | Liver | TMEM180 | 0.28 | 0.17 | enet | 36 | 0.17 | 1.7e-05 | -6.468 | -7.8 | 7.5e-15 | -0.46 | 0.53 | 0.34 | FALSE |
26 | GTEx | Lung | CYP17A1-AS1 | 0.06 | 0.08 | lasso | 3 | 0.06 | 1.6e-05 | 6.604 | 7.0 | 3.3e-12 | 0.83 | 0.13 | 0.83 | FALSE |
27 | GTEx | Nerve Tibial | CYP17A1-AS1 | 0.14 | 0.08 | lasso | 6 | 0.06 | 7.2e-05 | 6.594 | 6.7 | 1.8e-11 | 0.82 | 0.38 | 0.40 | FALSE |
28 | GTEx | Pituitary | NT5C2 | 0.19 | -0.01 | lasso | 10 | 0.01 | 1.8e-01 | -4.583 | -5.6 | 2.1e-08 | -0.25 | 0.07 | 0.07 | FALSE |
29 | GTEx | Skin Sun Exposed Lower leg | SUFU | 0.06 | 0.05 | enet | 12 | 0.06 | 8.4e-06 | -6.468 | 6.5 | 6.4e-11 | 0.40 | 0.86 | 0.11 | FALSE |
30 | GTEx | Skin Sun Exposed Lower leg | ACTR1A | 0.08 | 0.06 | enet | 10 | 0.07 | 2.7e-06 | -6.580 | 5.3 | 1.2e-07 | 0.33 | 0.81 | 0.11 | FALSE |
31 | GTEx | Testis | CYP17A1-AS1 | 0.14 | 0.08 | enet | 5 | 0.10 | 2.3e-05 | 5.787 | -5.9 | 4.6e-09 | -0.38 | 0.68 | 0.08 | FALSE |
32 | GTEx | Thyroid | SFXN2 | 0.28 | 0.06 | enet | 32 | 0.15 | 1.1e-11 | -1.986 | -5.4 | 7.9e-08 | -0.60 | 0.16 | 0.84 | FALSE |
33 | GTEx | Thyroid | WBP1L | 0.26 | 0.10 | enet | 9 | 0.13 | 2.1e-10 | 3.135 | -5.4 | 7.2e-08 | -0.20 | 1.00 | 0.00 | FALSE |
34 | NTR | Blood | ACTR1A | 0.03 | 0.03 | enet | 19 | 0.03 | 1.4e-09 | -4.348 | 6.3 | 2.3e-10 | 0.49 | 0.99 | 0.01 | FALSE |
35 | ROSMAP | Brain Pre-frontal Cortex | CNNM2 | 0.11 | 0.08 | lasso | 3 | 0.07 | 2.2e-09 | 6.255 | 6.2 | 5.7e-10 | 0.37 | 0.93 | 0.07 | FALSE |
36 | ROSMAP | Brain Pre-frontal Cortex | CYP17A1-AS1 | 0.15 | 0.18 | lasso | 6 | 0.19 | 1.3e-23 | 6.682 | 7.1 | 1.4e-12 | 0.81 | 0.80 | 0.20 | FALSE |
37 | YFS | Blood | ARL3 | 0.39 | 0.14 | enet | 30 | 0.20 | 7.0e-63 | 3.175 | 5.9 | 3.9e-09 | 0.46 | 1.00 | 0.00 | FALSE |
38 | YFS | Blood | NT5C2 | 0.13 | 0.10 | bslmm | 382 | 0.11 | 7.3e-35 | 6.556 | 5.5 | 3.6e-08 | 0.22 | 0.92 | 0.08 | FALSE |
39 | YFS | Blood | TRIM8 | 0.04 | 0.04 | lasso | 6 | 0.05 | 1.2e-15 | -4.630 | 5.2 | 1.6e-07 | 0.38 | 1.00 | 0.00 | FALSE |
40 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | AS3MT | 0.06 | 0.09 | enet | 6 | 0.07 | 1.3e-06 | 6.561 | -7.2 | 7.4e-13 | -0.80 | 0.12 | 0.88 | FALSE |
41 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | C10orf32 | 0.06 | 0.06 | blup | 54 | 0.08 | 1.2e-07 | 3.494 | -5.2 | 1.8e-07 | -0.81 | 0.48 | 0.52 | FALSE |
42 | The Cancer Genome Atlas | Breast Invasive Carcinoma | AS3MT | 0.05 | 0.05 | enet | 10 | 0.05 | 4.7e-11 | 6.561 | -6.0 | 1.7e-09 | -0.82 | 0.25 | 0.75 | FALSE |
43 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C10orf26 | 0.03 | 0.02 | enet | 5 | 0.02 | 1.6e-04 | -6.012 | -5.8 | 8.8e-09 | -0.40 | 0.90 | 0.02 | FALSE |
44 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SFXN2 | 0.12 | 0.09 | lasso | 4 | 0.10 | 4.4e-19 | 5.407 | -5.4 | 6.6e-08 | -0.16 | 1.00 | 0.00 | FALSE |
45 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | C10orf32 | 0.16 | 0.06 | blup | 54 | 0.10 | 1.3e-05 | 3.494 | -5.4 | 7.0e-08 | -0.80 | 0.08 | 0.85 | FALSE |
46 | The Cancer Genome Atlas | Esophageal Carcinoma | SFXN2 | 0.26 | 0.02 | blup | 48 | 0.10 | 4.9e-04 | 5.407 | -5.8 | 8.5e-09 | -0.37 | 0.01 | 0.71 | FALSE |
47 | The Cancer Genome Atlas | Glioblastoma Multiforme | AS3MT | 0.15 | 0.05 | blup | 62 | 0.10 | 5.1e-04 | 3.494 | -5.6 | 2.6e-08 | -0.83 | 0.04 | 0.57 | FALSE |
48 | The Cancer Genome Atlas | Glioblastoma Multiforme | SFXN2 | 0.27 | 0.02 | blup | 47 | 0.11 | 3.1e-04 | 5.407 | -5.2 | 2.1e-07 | -0.36 | 0.02 | 0.55 | FALSE |
49 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | AS3MT | 0.05 | 0.05 | blup | 62 | 0.06 | 1.1e-07 | 7.550 | -5.8 | 8.7e-09 | -0.88 | 0.01 | 0.99 | FALSE |
50 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | AS3MT | 0.04 | 0.05 | enet | 3 | 0.04 | 8.6e-06 | 6.561 | -6.5 | 5.6e-11 | -0.85 | 0.12 | 0.86 | FALSE |
51 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | SFXN2 | 0.20 | 0.08 | blup | 48 | 0.13 | 9.3e-07 | 5.407 | -5.6 | 2.8e-08 | -0.33 | 0.13 | 0.82 | FALSE |
52 | The Cancer Genome Atlas | Lung Adenocarcinoma | TMEM180 | 0.08 | 0.07 | blup | 52 | 0.09 | 1.9e-10 | -6.473 | 6.2 | 4.8e-10 | 0.39 | 0.01 | 0.99 | FALSE |
53 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | TMEM180 | 0.05 | 0.02 | blup | 52 | 0.04 | 1.5e-05 | -5.634 | 5.9 | 4.8e-09 | 0.39 | 0.02 | 0.94 | FALSE |
54 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | SUFU | 0.03 | 0.02 | blup | 90 | 0.02 | 1.5e-02 | -6.568 | -6.0 | 1.6e-09 | -0.33 | 0.03 | 0.77 | FALSE |
55 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | AS3MT | 0.13 | 0.14 | blup | 62 | 0.13 | 5.6e-06 | 7.265 | -6.6 | 3.4e-11 | -0.92 | 0.03 | 0.97 | FALSE |
56 | The Cancer Genome Atlas | Prostate Adenocarcinoma | AS3MT | 0.16 | 0.21 | lasso | 9 | 0.24 | 2.5e-24 | 6.531 | -5.4 | 7.0e-08 | -0.84 | 0.39 | 0.61 | FALSE |
57 | The Cancer Genome Atlas | Prostate Adenocarcinoma | TMEM180 | 0.16 | 0.27 | lasso | 4 | 0.27 | 4.3e-28 | -6.395 | -6.4 | 2.0e-10 | -0.40 | 0.02 | 0.98 | FALSE |
58 | The Cancer Genome Atlas | Rectum Adenocarcinoma | C10orf32 | 0.17 | 0.14 | blup | 52 | 0.14 | 3.2e-04 | 7.265 | -7.1 | 9.5e-13 | -0.94 | 0.02 | 0.75 | FALSE |
59 | The Cancer Genome Atlas | Thyroid Carcinoma | AS3MT | 0.23 | 0.18 | lasso | 3 | 0.18 | 1.8e-17 | 6.531 | -6.2 | 4.4e-10 | -0.85 | 0.83 | 0.17 | FALSE |
60 | The Cancer Genome Atlas | Thyroid Carcinoma | C10orf26 | 0.06 | 0.05 | lasso | 5 | 0.04 | 4.1e-05 | 6.925 | -6.6 | 3.2e-11 | -0.75 | 0.07 | 0.88 | FALSE |
61 | The Cancer Genome Atlas | Thyroid Carcinoma | CYP17A1 | 0.04 | 0.02 | lasso | 1 | 0.02 | 3.9e-03 | 7.550 | -7.5 | 4.3e-14 | -1.00 | 0.01 | 0.92 | FALSE |